TOLVAPTORIS 30 Tolvaptan (30mg) Tolvaptan is a medication used to treat certain conditions characterized by excess fluid retention in the body, specifically hyponatremia (low blood sodium levels) and autosomal dominant polycystic kidney disease (ADPKD). It is classified as a vasopressin V2 receptor antagonist and helps regulate the body's water balance by increasing the excretion of excess water through urine. Here are some key points about Tolvaptan: Indications: Hyponatremia: Tolvaptan is used to treat hyponatremia in patients with congestive heart failure (CHF), cirrhosis of the liver, and the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Hyponatremia is a condition where the blood sodium levels are dangerously low, often due to an imbalance in water and sodium regulation. Autosomal Dominant Polycystic Kidney Disease (ADPKD): Tolvaptan is also approved for the treatment of ADPKD, a genetic condition characterized by the development of multiple fluid-filled cysts in the kidneys. It can slow down the progression of kidney enlargement and preserve kidney function in some patients with ADPKD. Mechanism of Action: Tolvaptan works by blocking the action of vasopressin, a hormone that regulates water reabsorption in the kidneys. By inhibiting vasopressin's effects on the V2 receptors, Tolvaptan increases water excretion, leading to the removal of excess fluid from the body. Dosage: The dosage of Tolvaptan may vary depending on the specific condition being treated and the patient's individual circumstances. It is typically taken orally once daily, usually in the morning. Side Effects: Common side effects of Tolvaptan may include thirst, dry mouth, increased urination, and elevated blood sodium levels (hypernatremia). It is essential to monitor the patient's blood sodium levels regularly while taking Tolvaptan. In rare cases, Tolvaptan can lead to liver injury, so liver function tests are typically conducted during treatment. Precautions: Tolvaptan should be used cautiously in patients with liver disease, as it may increase the risk of liver problems. It is not recommended for use during pregnancy or in patients with an allergy to any component of the medication. Monitoring: Patients taking Tolvaptan need regular monitoring of their blood sodium levels, fluid intake, and urine output to ensure that the medication is effectively managing fluid balance without causing significant sodium imbalances. Discontinuation: The discontinuation of Tolvaptan should be done under the guidance of a healthcare provider, as abrupt cessation can lead to rapid fluid retention and worsening of symptoms. Tolvaptan can be an important treatment option for individuals with conditions characterized by fluid retention and low blood sodium levels. However, its use should be carefully monitored and managed by a healthcare provider, and the decision to use Tolvaptan should take into account the specific medical condition and individual patient factors. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/tolvaptoris-30-133391